Vastagbélrák: vizsgálatok itt: Belgium
77 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleOutcomes of Knife-Assisted Full-Thickness Resection for Rectal Lesions: A Multicenter Study
- Where
- Ghent
- Életkor
- 18 év and over
- People
- 150
- Run by
- University Hospital, Ghent
See details and how to joinNCT07923682 - 1/2. fázisTaking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Brussels, Edegem, Leuven, Libramont-Chevigny, Liège, Namur
- Életkor
- 18 év and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - 3. fázisTaking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Brussels, Ghent, Haine-Saint-Paul, Kortrijk
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - 3. fázisTaking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Charleroi, Edegem, Leuven, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 1020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - 1/2. fázisTaking peopleA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Where
- Anderlecht, Edegem, Leuven, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05379595 · EU 2023-506517-22-00 - 1. fázisTaking peoplePhase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Where
- Charleroi
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Sairopa B.V.
See details and how to joinNCT05856981 - 3. fázisTaking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Anderlecht, Edegem, Gent, Kortrijk, La Louvière, Leuven, Liège
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - 3. fázisTaking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Anderlecht, Edegem, Kortrijk, La Louvière, Leuven, Liège
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - 1/2. fázisTaking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Anderlecht, Gent, Namur, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Edegem, Gent, Jette, Leuven, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - 2. fázisTaking peopleNeoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Where
- Anderlecht, Bonheiden, Ghent, Leuven, Liège, Ostend, Woluwe-Saint-Lambert
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Solstice Oncology, Inc.
See details and how to joinNCT07808151 · EU 2026-527233-58-00 - 3. fázisNot yet taking people in BelgiumStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Anderlecht, Bonheiden, Charleroi, La Louvière, Libramont-Chevigny, Namur, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 · EU 2026-525883-17-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Charleroi, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseTaking peopleBiopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot Study
- Where
- Brussels
- Életkor
- Up to 100 év
- People
- 30
- Run by
- Jules Bordet Institute
See details and how to joinNCT07474025 - 2/3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Where
- Bonheiden, Edegem, Leuven, Roeselare, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00 - 1. fázisTaking peopleA Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Where
- Brussels, Ghent
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT06004245 · EU 2023-503170-20-01 - 2. fázisTaking peopleA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- Brussels, Ghent, La Louvière, Leuven, Roeselare
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - 1/2. fázisTaking peopleFirst-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
- Where
- Brussels
- Életkor
- 18 év to 75 év
- People
- 90 worldwide
- Run by
- Brenus Pharma
See details and how to joinNCT06934538 - 1/2. fázisTaking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Bonheiden, Brussels, Leuven, Roeselare
- Életkor
- 18 év and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - 3. fázisTaking peopleA Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Where
- Anderlecht, Bonheiden, Charleroi, Edegem, Gent, Jette, Leuven, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- AbbVie
See details and how to joinNCT07525206 · EU 2025-521712-19-00 - 3. fázisTaking peopleA Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)
- Where
- Anderlecht, Gent, Kortrijk, La Louvière, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Summit Therapeutics Inc.
See details and how to join2025-521587-35-00 · EU 2025-521587-35-00 - 2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Where
- Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- AbbVie
See details and how to joinNCT07023289 · EU 2024-518015-19-00 - 3. fázisTaking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Charleroi, Gent, Leuven, Roeselare
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - 1. fázisTaking peopleA Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Where
- Ghent
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Bayer
See details and how to joinNCT07535112 · EU 2025-523648-11-00